• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Cannapharmarx Inc (OP: CPMD )

    0.0099 +0.0017 (+20.73%)
    Streaming Delayed Price Updated: 12:49 PM EDT, Oct 11, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 151,831
    Open 0.0110
    Bid (Size) N/A (0)
    Ask (Size) N/A (0)
    Prev. Close 0.0082
    Today's Range 0.0080 - 0.0110
    52wk Range 0.0001 - 0.0279
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    CannaPharmaRx Receives Multiple Purchase Orders and Begins Delivery of Product
    Via ACCESSWIRE
    Q1 2024 Financial Results
    Via ACCESSWIRE

    Performance

    YTD
    +661.54%
    +661.54%
    1 Month
    +23.75%
    +23.75%
    3 Month
    -1.00%
    -1.00%
    6 Month
    -34.00%
    -34.00%
    1 Year
    +23.75%
    +23.75%

    More News

    Read More
    CORRECTION FROM SOURCE: CannaPharmaRx to Host Investor Conference Call
    Via ACCESSWIRE
    CannaPharmaRx to Host Investor Conference Call
    Via ACCESSWIRE
    CannapharmaRx Pays Off Convertible Notes
    Via ACCESSWIRE
    CannapharmaRx Receives First Purchase Order and Begins Shipment of Product
    Via ACCESSWIRE
    CannaPharmaRx Completes First Harvests
    Via ACCESSWIRE
    CannaPharmaRx CEO Provides Annual Update Message
    Via ACCESSWIRE
    CannaPharmaRx to Hold Investor Conference Call
    Via ACCESSWIRE
    Cannapharmarx Partners With ICAN To Expand Cannabis Distribution In Latin America
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    CannaPharmaRx Executes Multi-Year Supply Agreement with ICAN to Create Distribution Network in the Latin Americas
    Via ACCESSWIRE
    CannaPharmaRx Achieves IMC-GAP and GACP Certifications Completing a Significant Milestone Towards Revenue Acceleration
    Via ACCESSWIRE
    CannaPharmaRx Finalizes Multi-Million Dollar Israeli Supply Agreement with Cantek
    Via ACCESSWIRE
    Cannabis Industry Changes As Marijuana Rescheduling Looms
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    CannaPharmaRx Expands Board of Directors
    Via ACCESSWIRE
    Cannabis Movers & Shakers: Delaware's New Marijuana Commissioner And Latest Industry Appointments
    Via Benzinga
    CannaPharmaRx Appoints Dean Medwid as New CEO
    Via ACCESSWIRE
    CannaPharmaRx Signs Agreement with Nasha Genetics
    Via ACCESSWIRE
    CannaPharmaRx Signs Supply Agreement With Y.S.A For Up To $15M Annually Of Commercial Cannabis
    Via Benzinga
    CannaPharmaRx Signs Supply Agreement with Y.S.A Holdings for up to $15 Million Annually of Commercial Cannabis
    Via ACCESSWIRE
    New Leaf Ventures Enters Into Genetics Supply Agreement With CannaPharmaRX
    Via Benzinga
    CannaPharmRx, Inc. Completes Purchase of LTB Management, an E- Commerce and Financial Platform Company, and Launches New Corporate Website
    Via ACCESSWIRE
    CannaPharmRx, Inc. Adds to Revenue Streams by Purchasing E-Commerce and Financial Platform Company
    Via ACCESSWIRE
    CannaPharmaRx Evaluates Investigation into Market Manipulation and Potentially Illegal Trading of Stock
    Via ACCESSWIRE
    CannaPharmaRx Releases Year-in-Review Letter to Shareholders and Discusses Revenue Opportunities for 2023
    Via ACCESSWIRE
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.